ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new daily pill, NKT3964, in adults with advanced solid tumors (like ovarian, endometrial, breast, lung, or stomach cancer) that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose, whi…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called LY4170156 in people with advanced solid tumors, such as ovarian, lung, and pancreatic cancers. The drug is designed to target and kill cancer cells that have a specific marker (folate receptor alpha). The trial has two parts: first, finding the …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Could a drug already approved for some cancers help people with rare tumors?
Disease control Recruiting nowThis study tests a drug called atezolizumab in people with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). The drug is already approved for certain cancers, and researchers want to see if it works for other cancer types with these ge…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, LY4257496, that delivers radiation directly to cancer cells with a specific protein (GRPR). It is for adults with advanced breast, colorectal, prostate, or endometrial cancer that has spread. The goal is to see if the drug is safe and shrinks tumors. …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called LY4175408 in people with advanced lung, endometrial, or triple-negative breast cancers that have not responded to standard treatments. The drug is designed to seek out and attack cancer cells carrying a specific marker (PTK7). The main goals are…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Massive new cancer registry aims to unlock secrets of ovarian and endometrial cancers
Knowledge-focused Recruiting nowThis study is a large registry that will follow about 2,000 people in Germany with advanced ovarian or endometrial cancer. Researchers will collect information on treatments, side effects, quality of life, and survival to understand what really happens in everyday medical practic…
Matched conditions: ENDOMETRIAL NEOPLASMS
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated May 01, 2026 16:07 UTC